08 June 2021 : Original article
Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis jirovecii Pneumonia in Kidney Transplantation Recipients
Jia Xu12345ABCDEF, Yedong Yu12345ABCD, Junhao Lv12345ABCD, Sisi Yang6ABCD, Jianyong Wu12345AD, Jianghua Chen12345AD, Wenhan Peng12345AEFG*DOI: 10.12659/AOT.931059
Ann Transplant 2021; 26:e931059
Table 1 Baseline characteristics.
| Recipient | Age (yr) | Gender | BMI (kg/m2) | RD | Dialysis form | Dialysis time | Transplant time | Transplant form | Hypertension | Diabetes | LVEF (%) | Immunosuppressant |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | Male | 22.5 | Unknown | PD | 4 (yr) | 1 (yr) | DCD | + | − | 60 | Tacrolimus +MMF +GC |
| 2 | 36 | Male | 20.4 | Unknown | HD | 0.5 (yr) | 5 (yr) | Living-related | + | − | n/a | Tacrolimus +MMF +GC |
| 3 | 34 | Male | 17.9 | Unknown | HD | 4 (yr) | 5 (month) | DCD | + | − | 61 | Tacrolimus +MMF +GC |
| 4 | 62 | Male | 21.6 | Unknown | PD | 4 (yr) | 2 (yr) | DCD | + | + | 69 | CsA +MPA +GC |
| 5 | 40 | Male | 19.8 | Polycystic kidney | HD | 5 (yr) | 1 (yr) | DCD | + | − | n/a | Tacrolimus +MMF +GC |
| 6 | 54 | Male | 25.3 | Diabetic nephropathy | HD | 8 (yr) | 5 (month) | DCD | + | + | 59 | Tacrolimus +MMF +GC |
| 7 | 45 | Female | 17.5 | Unknown | PD | 0.5 (yr) | 9 (yr) | DCD | + | − | 85 | Tacrolimus +MMF +GC |
| 8 | 30 | Male | 20.5 | Unknown | HD | 10 (month) | 1 (yr) | Living-related | + | − | 62 | Tacrolimus +MMF +GC |
| 9 | 43 | Male | 21.0 | Unknown | HD | 1 (month) | 9 (yr) | Living-related | + | − | 64 | Tacrolimus +MMF +GC |
| 10 | 35 | Female | 17.3 | HSP | None | 0 | 1 (yr) | Living-related | + | − | n/a | Tacrolimus +MMF +GC |
| 11 | 61 | Male | 19.9 | Unknown | HD | 9 (yr) | 5 (month) | DCD | + | − | 70 | Tacrolimus +MMF +GC |
| 12 | 28 | Male | 23.2 | Unknown | None | 0 | 1 (yr) | Living-related | + | − | n/a | Tacrolimus +MMF +GC |
| BMI – body mass index; RD – renal disease; HSP – Henoch-Schönlein purpura nephritis; PD – peritoneal dialysis; HD – hemodialysis; DCD – cardiac death donors; LVEF – left ventricular ejection fractions; CsA – ciclosporin; MMF – mycophenolate mofetil; MPA – mycophenolic acid; GC – glucocorticoid; n/a – not available; ‘+’ – positive; ‘−’ – negative. | ||||||||||||